Sequenom Inc., a diagnostics testing and genetic analysis company, said it would pay $14 million to settle an investor class-action lawsuit arising from mistakes in the development of a prenatal test for Down Syndrome.
Follow this link:
Sequenom in $14M settlement over test delay